New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2014
07:46 EDTSRPTSarepta price target raised to $35 from $22 at RW Baird
Baird raised its price target on Sarepta following its update on pulmonary data that provides incremental evidence of efficacy of its 6MWT results from last month. The firm expects the next catalyst to be clarity on its pivotal trial design. Shares are Outperform rated.
News For SRPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
10:32 EDTSRPTOptions with increasing implied volatility
Subscribe for More Information
10:13 EDTSRPTOptions with increasing implied volatility
Options with increasing implied volatility: ESPR SRPT CX RAX YY SPLK QIHU HFC OWW BBY
July 29, 2015
06:38 EDTSRPTBioMarin price target raised to $163 from $147 at Piper Jaffray
Subscribe for More Information
July 28, 2015
10:38 EDTSRPTOptions with increasing implied volatility
Subscribe for More Information
July 27, 2015
10:40 EDTSRPTIsis 'most obvious' Biogen takeover target, TheStreet's Feuerstein says
Subscribe for More Information
July 22, 2015
17:06 EDTSRPTSarepta announce publication of Phase I clinical data of AVI-7288
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use